Similar articles

• [beta2-Sympathomimetics: dangers in asthma therapy? Lessons from the SMART1 Study].

  Riedl-Seifert R. Riedl-Seifert R. Dtsch Med Wochenschr. 2007 Mar 23;132(12):633; author reply 633-4. doi: 10.1055/s-2007-973592. Dtsch Med Wochenschr. 2007. PMID: 17357910 German. No abstract available.
• Toxicity of aerosols.

  Aviado DM. Aviado DM. J Clin Pharmacol. 1975 Jan;15(1 Pt 2):86-104. doi: 10.1002/j.1552-4604.1975.tb01436.x. J Clin Pharmacol. 1975. PMID: 803273 Review. No abstract available.
• [Update on beta-adrenergic agonists and corticosteroid aerosols].

  Spector S. Spector S. Rev Alerg Mex. 1993 Nov-Dec;40(6):i-iv. Rev Alerg Mex. 1993. PMID: 9296815 Spanish. No abstract available.
• Bronchodilators, hypokalaemia, and fatal asthma.

  Chapman KR, Rebuck AS. Chapman KR, et al. Lancet. 1985 Jul 20;2(8447):162. doi: 10.1016/s0140-6736(85)90272-7. Lancet. 1985. PMID: 2862360 No abstract available.
• Beta-adrenergic bronchodilators.

  Nelson HS. Nelson HS. N Engl J Med. 1995 Aug 24;333(8):499-506. doi: 10.1056/NEJM199508243330807. N Engl J Med. 1995. PMID: 7623883 Review. No abstract available.